Formulation and manufacturing delayed Sanofi/Merck’s European shingles vaccine until now
This article was originally published in Scrip
The UK has launched Europe’s first national shingles vaccination campaign, using Sanofi Pasteur MSD’s Zostavax, which will be offered to eligible seniors alongside their seasonal flu jab.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.